pharma
dog
News
when
Latest
Archive
by source
All Sources
Sources Page
Jobs
department
Clinical
Regulatory
Medical Affairs
Commercial
R&D / Discovery
Biostatistics / Data
Manufacturing / CMC
Market Access
therapeutic area
Oncology
Immunology
Neuroscience
Cardiovascular
Metabolic
Rare Disease
Infectious Disease
location & type
Remote Only
US Only
California
Massachusetts
Internships
Phase 3 Roles
All Jobs →
Drugs
by stage
Marketed
Phase 3
Phase 2
Phase 1
Preclinical
browse
Most catalysts
Recently active
All drugs →
Companies
Patent cliff
Calendar
what
Trial readouts
PDUFA dates
Approvals
Earnings
when
Upcoming
Month grid
Recently passed
◐
Sign In
Subscribe
home
jobs
news
search
LEADING · news · pharmadog
← back to LEADING
News mentioning LEADING
652
stories
Sep 25, 26
Lundbeck to move US digs to Boston as it eyes bigger innovation frontiers
fiercebiotech
Sep 25, 26
Angiographic Catheter Recall: Boston Scientific Removes Imager II Angiographic Catheters
fda medwatch
Sep 25, 26
Roche's Genentech inks $1.5B bispecific pact with fast-rising Earendil
fiercebiotech
Sep 24, 26
Chutes & Ladders—Travere chief makes way for former Amicus CEO
fiercebiotech
Sep 24, 26
Acadia drug fails mid-stage study in Alzheimer's psychosis, leading to modified Phase 3
endpoints
Sep 24, 26
Lilly’s latest China drug deal; Immunovant’s setback in lupus
biopharma dive
Sep 24, 26
Kyverna steps closer to FDA-first CAR T for an autoimmune condition with durability data
biospace
Sep 24, 26
Acadia misses mark in Alzheimer’s but concludes phase 3 ‘absolutely worth’ pursuing
fiercebiotech
Sep 23, 26
New approach methodologies in safety and toxicology testing: Why proving repeatability is the next hurdle for widespread adoption
fiercebiotech
Sep 23, 26
9 pharma leaders sound ‘alarm bells’ on biotech’s decline in Europe
biopharma dive
Sep 23, 26
Roivant reports Phase 2b lupus failure for an FcRn drug
endpoints
Sep 23, 26
The latest in the legal saga for youth gender-affirming care in the U.S.
stat
Sep 23, 26
Opinion: Mentally ill women deserve more support to have children
stat
Sep 23, 26
ReCode CEO Suliman leaves cystic fibrosis mission in mentee’s hands
biospace
Sep 23, 26
Early Alert: Ventilator Issue from React Health
fda medwatch
Sep 22, 26
Viking shares surge on updated obesity drug data
biopharma dive
Sep 22, 26
‘It’s just survival now’: Why is almost a third of Boston’s life sciences lab space sitting vacant?
fiercebiotech
Sep 22, 26
An orexin drug’s ‘proof-of-concept’ in ADHD; Cue’s ‘unwarranted’ share slide
biopharma dive
Sep 22, 26
Boehringer Ingelheim bets up to $1B in AI-centered solid tumor collab with Envisagenics
biospace
Sep 22, 26
New federal autism committee head has financial ties to leucovorin
stat
Sep 22, 26
Siemens Healthineers and Novo team up on fatty liver disease awareness, testing
fiercebiotech
Sep 21, 26
Novo talks up drug launches in effort to win back investors
biopharma dive
Sep 21, 26
FDA approves ataxia-telangiectasia drug; Alkermes reports ADHD data
endpoints
Sep 21, 26
Iambic signs AbbVie deal, releases next generation of Enchant model
endpoints
Sep 21, 26
Telix buys ITM in bid to create a ‘radiopharmaceutical powerhouse’
biopharma dive
Sep 21, 26
Behind the outcomes: How whole-patient support is reshaping oncology care
biopharma dive
Sep 21, 26
Are healthcare systems really ready for GLP-1s?
biopharma dive
Sep 21, 26
Addiction clinics see rising cases of kratom and 7-OH withdrawal
stat
Sep 21, 26
Skeptical about modern medicine? I know the feeling — and want to listen
stat
Sep 21, 26
Mikhail, Davis on board with regulatory framework tailored to rare disease therapies
biospace
← prev
page 6 of 22
next →
